Induction chemotherapy in head and neck cancer patients followed by concomitant docetaxel-based radiochemotherapy

European Journal of Cancer Care

Volumn 20, Issue 4, 2011, Pages 503-507

  Mencoboni, M ^a   Grillo Ruggieri, F ^b   Salami, A ^c   Scasso, F ^d   Rebella, L ^a   Grimaldi, A ^b   Dellepiane, M ^c   Moratti, G ^d   Bruzzone, A ^e   Spigno, F ^c   Ghio, R ^e   Figliomeni, M ^c  

^a VILLA SCASSI HOSPITAL   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Neurology Department   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Chemotherapy; Head and neck cancer; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; TAXOID;

ADULT; AGED; ARTICLE; CARCINOMA; CLINICAL TRIAL; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; REMISSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; REMISSION INDUCTION; TAXOIDS;

EID: 79958256985     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2010.01185.x     Document Type: Article

References (20)

1. Adelstein D.J. (1999) Induction chemotherapy in head and neck cancer. Hematology/Oncology Clinics of North America 13, 689-698.
2. Adelstein D.J. & LeBlanc M. (2006) Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? Journal of Clinical Orthodontics 24, 2624-2628.
3. Adelstein D.J., Saxton J.P., Lavertu P. etal. (2002) Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. Journal of Clinical Oncology 20, 1405-1410.
4. Argiris A., Jayaram P. & Pichardo D. (2005) Revisiting induction chemotherapy for head and neck cancer. References and reviews. Oncology (Williston Park, N.Y.) 19, 932-934.
5. Bonner J.A., Harari P.M. & Giralt J. (2006) Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. The New England Journal of Medicine 354, 567-578.
6. Clinical Cancer Advances, ASCO (2006) Clinical Cancer Advances. Journal of Clinical Oncology 25, 28.
7. Cohen E.E., Lingen M.W. & Vokes E.E. (2004) The expanding role of systemic therapy in head and neck cancer. Journal of Clinical Oncology 22, 1743-1752.
8. Domenge C., Hill C., Lefebvre J.L. etal. (2000) Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. The British Journal of Cancer 83, 1594-1598.
9. Fleming T.R. (1982) One-sample multiple testing procedure for phase II clinical trials. Biometrics 38, 143-151.
10. Hitt R., Paz-Ares L., Brandariz A. etal. (2002) Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck: long-term results of a phase II trial. Annals of Oncology 13, 1665-1673.
11. Hitt R., Lopez-Pousa A., Martinez-Trufero J. etal. (2005) Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. Journal of Clinical Oncology 23, 8636-8645.
12. Kotwall C., Sato K., Razack M.S. etal. (1987) Metastatic patterns in squamous cell cancer of the head and neck. American Journal of Surgery 154, 439-442.
13. Laramore G.E., Scott C.B., Al-Sarraf M. etal. (1992) Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. International Journal of Radiation Oncology, Biology, Physics 23, 705-713.
14. Paccagnella A., Orlando A., Marchiori C. etal. (1994) Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. Journal of the National Cancer Institute 86, 265-272.
15. Posner M.R., Glisson B., Frenette G. etal. (2001) Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. Journal of Clinical Oncology 19, 1096-1104.
16. Schrijvers D. & Vermorken J.B. (2005) Taxanes in the treatment of head and neck cancer. Current Opinion in Oncology 17, 218-224.
17. Schuller D.E., Metch B., Mattox D. etal. (1988) Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope 98, 1205-1211.
18. Tishler R.B., Posner M.R., Norris C.M., Jr etal. (2006) Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck. International Journal of Radiation Oncology, Biology, Physics 65, 1036-1044.
19. Vermorken J.B., Remenar E., Van Herpen C. etal. (2004) Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head and neck: a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971). Journal of Clinical Oncology 22, 490; (suppl; abstr 5508).
20. Vokes E.E., Kies M.S., Haraf D.J. etal. (2006) Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. Journal of Clinical Oncology 18, 1652-1661. 2000 No 17 (June 10), pp. 2624-2628.